comparemela.com

Latest Breaking News On - Haffkine biopharma - Page 1 : comparemela.com

Mumbai: Shortage of essential medicine plagues J J

Desperate patients and helpless medical staff at Jamshetji Jeejeebhoy (JJ) hospital are grappling with the shortage of medicines, most of which have been listed as out of stock.

Phase-3 Trials Show Covaxin 93 4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In Manufacturing

Phase-3 Trials Show Covaxin 93 4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In Manufacturing
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Haffkine Biopharma to produce 22 8 cr doses of Covaxin per annum

Haffkine Biopharma to produce 22.8 cr doses of Covaxin per annum With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country with the help from the Centre Photo Courtesy: IANS Engagement: 0 The Centre on Wednesday took steps to accelerate domestic vaccine production. Mumbai-based Haffkine Biopharma will produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech. With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country with the help from the Centre.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.